Ownership history in Qube Research & Technologies Ltd · 6 quarters on record
This page tracks every 13F SEC filing in which Qube Research & Technologies Ltd reported a position in DIAMEDICA THERAPEUTICS INC (DMAC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 39,549 | +2,620 | +7.1% | 0.00% | $272K | $6.87 |
| 2025 Q1 | REDUCED | 36,929 | -57,840 | -61.0% | 0.00% | $140K | $3.79 |
| 2024 Q4 | ADDED | 94,769 | +42,680 | +81.9% | 0.00% | $515K | $5.43 |
| 2024 Q3 | ADDED | 52,089 | +33,304 | +177.3% | 0.00% | $218K | $4.19 |
| 2020 Q4 | REDUCED | 18,785 | -12,449 | -39.9% | 0.00% | $190K | $10.14 |
| 2020 Q3 | INITIATED | 31,234 | — | — | 0.00% | $132K | $4.24 |
As of 2025 Q4 — sorted by position size